Morgan Stanley Global Cord Blood Corp Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.99 - $2.99 $188 - $188	-63 Reduced 0.07%	87,064 $260,000
Q3 2022 Nov 14, 2022	SELL	$2.05 - $3.0 $25,897 - $37,899	-12,633 Reduced 12.66%	87,127 $260,000
Q2 2022 Oct 27, 2022	BUY	$2.2 - $3.98 $177,691 - $321,460	80,769 Added 425.3%	99,760 $295,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $3.98 $177,691 - $321,460	80,769 Added 425.3%	99,760 $295,000
Q1 2022 Oct 27, 2022	SELL	$3.74 - $4.55 $302,076 - $367,498	-80,769 Reduced 80.96%	18,991 $73,000
Q1 2022 May 13, 2022	BUY	$3.74 - $4.55 $62,308 - $75,803	16,660 Added 714.71%	18,991 $73,000
Q4 2021 Feb 14, 2022	BUY	$3.9 - $4.75 $163 - $199	42 Added 1.83%	2,331 $10,000
Q3 2021 Nov 15, 2021	BUY	$4.57 - $5.39 $10,460 - $12,337	2,289 New	2,289 $11,000

44.8K

Ticker CO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 133,915,000
Description
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matchin...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.